Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of potassium hydroxybenzovalerate tablets in acute ischemic stroke
CTR20132923Phase 2Suspended
- Sponsor
- Yunnan Biovalley Pharmaceutical
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of potassium hydroxybenzovalerate in ischemic stroke, sponsored by Yunnan Biovalley Pharmaceutical. Started Sep 2014; status: suspended.
02
Drugs
potassium hydroxybenzovalerate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20132923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132923.